查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403515

到 2030 年电脑辅助检测市场预测：按产品类型、适应症、应用、最终用户和地区进行的全球分析

Computer Aided Detection Market Forecasts to 2030 - Global Analysis By Product Type, Indication, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球电脑辅助侦测市场规模为 8.18 亿美元，预计在预测期内将以 7.9% 的复合年增长率成长，到 2030 年达到 13.92 亿美元。

电脑辅助检测 (CAD) 是一组演算法，使用模式识别来帮助医生解读医学影像。电脑辅助检测软体透过X光磁振造影、超音波影像、电脑断层扫描等显像模式辅助诊断冠状动脉疾病、癌症、心血管疾病、神经系统疾病等各种疾病。

根据世界卫生组织（WHO）估计，到2022年，癌症将成为全球第一大死因，到2020年将导致约1,000万人死亡，即几乎六分之一的人死亡。

对疾病早期检测的需求不断增长

早期发现该疾病对于增加成功治疗的可能性和改善患者的治疗效果至关重要。与诊断成像设备整合的 CAD 系统可帮助放射科医生透过分析影像并突出显示潜在的关注区域来及早发现疾病。此外，癌症、心血管疾病和神经系统疾病等慢性疾病的盛行率不断增加，增加了早期诊断的需求。因此，疾病早期检测需求的不断增长成为加速市场需求的关键因素。

实施成本高

高实施成本是电脑辅助侦测（CAD）系统进入市场的主要抑制因素。实施 CAD 系统需要大量投资，包括软体采集费用、硬体基础设施和医疗保健专业人员培训成本。 CAD 软体本身可能很昂贵，特别是如果它是为特定的医学专业或显像模式设计的。此外，支援 CAD 系统所需的硬体（例如高效能电脑和储存解决方案）也会推高整体实施成本。

医疗图像技术的演变

电脑断层扫描 (CT)、磁振造影(MRI) 和乳房 X 光摄影等医疗图像技术的持续进步，为更先进、更详细的诊断能力铺平了道路。这些进步不仅提高了医疗图像的质量，还为 CAD 系统创造了机会，使其能够更好地检测细微的异常情况并协助医疗专业人员做出准确的诊断。医疗图像技术的此类创新将加速市场扩张。

资料隐私

CAD 实施包括处理和储存敏感的患者资料，例如医学影像和相关医疗记录。 CAD 系统分析并解释这些资讯，引发对潜在违规和诈欺存取的担忧。维护患者资料的隐私和安全对于遵守医疗保健法规以及建立患者和医疗保健提供者的信任至关重要。因此，资料隐私是一个主要问题并抑制了市场需求。

COVID-19 的影响

大流行期间对医疗保健和诊断的高度关注凸显了 CAD 等先进技术在疾病检测和监测方面的重要性。对更准确、更有效率的诊断工具的需求不断增长，推动了人们对 CAD 解决方案的兴趣，以帮助解释医学影像，特别是像 COVID-19 这样的呼吸道疾病。然而，疫情也为CAD市场带来了挑战。医疗机构的财务限制和供应链中断正在影响 CAD 系统的实施。

核磁共振成像领域预计将在预测期内成为最大的领域

预计核磁共振成像领域将占最大份额。在电脑辅助检测中，核磁共振成像在提高影像分析的准确性和效率方面发挥着重要作用。 CAD 系统利用核磁共振成像产生的详细影像来识别可能表明疾病或状况存在的潜在异常或可疑模式。此外，NRI 和 CAD 技术的整合提高了检测率、减少了误报并提高了整体诊断准确性。

预计肿瘤学在预测期内将经历最高的复合年增长率。

预计肿瘤学领域在预测期内将出现良好的成长。 CAD 技术透过分析医疗图像资料帮助医疗保健专业人员早期检测和表征癌症病变，从而在肿瘤学中发挥变革性作用。在乳房 X 光检查、 电脑断层扫描和 MRI 等模式中，CAD 系统利用先进的演算法来识别细微的异常、潜在的肿瘤以及可能预示征兆的组织结构不规则性。

比最大的地区

在估计期间，亚太地区占据最大的市场占有率。人们越来越认识到早期疾病检测的好处以及癌症等疾病盛行率的上升，推动了该地区对 CAD 解决方案的需求。亚太地区各国政府正大力投资医疗保健现代化，为 CAD 市场扩张创造有利的环境。此外，在中国和印度等人口众多、疾病负担高的国家，CAD 系统因其在提高诊断准确性和效率方面的作用而获得认可。

复合年增长率最高的地区：

由于稳健的医疗基础设施和慢性病的高盛行率使 CAD 成为诊断工作流程的关键组成部分，预计北美在预测期内将出现盈利成长。尤其美国，由于在研发方面的大量投资、成熟的医疗保健行业以及积极整合最尖端科技的方式，在北美 CAD 市场占据主导地位。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球电脑辅助检测市场：依产品类型

  • 腹部CAD
  • 摄护腺CAD
  • 乳房电脑辅助设计
  • 心血管CAD
  • 其他产品类型

第六章全球电脑辅助检测市场：依指标分类

  • 超音波共振成像
  • X射线摄影
  • 磁振造影
  • CT检查
  • 核磁共振成像
  • 乳房X光检查
  • 其他适应症

第七章全球电脑辅助侦测市场：依应用分类

  • 肿瘤学
    • 大肠直肠癌
    • 乳癌
    • 摄护腺癌
    • 肺癌
    • 骨癌
    • 肝癌
  • 心血管和神经系统癌症

第八章全球电脑辅助检测市场：依最终用户分类

  • 诊断中心
  • 医院
  • 其他最终用户

第九章全球电脑辅助检测市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Hologic, Inc
  • CANON Medical Systems Corporation
  • EDDA Technology, Inc
  • Koninklijke Philips NV
  • Siemens
  • FUJIFILM Holdings Corporation
  • NANO-X Imaging LTD.
  • General Electric
  • IBM
  • Riverain Technologies
  • iCAD Inc
  • Median Technologies
  • Carestream Health
  • Shimadzu Analytical（India）Pvt. Ltd
  • Karyopharm
Product Code: SMRC24740

According to Stratistics MRC, the Global Computer Aided Detection Market is accounted for $818 million in 2023 and is expected to reach $1392 million by 2030 growing at a CAGR of 7.9% during the forecast period. Computer-aided detection (CAD) is a collection of algorithms that use pattern recognition to help physicians interpret medical images. The computer-aided detection software aids in the diagnosis of various diseases, including coronary artery disease, cancer, cardiovascular diseases, and neurological diseases, through imaging modalities such as x-ray imaging, magnetic resonance imaging, ultrasound imaging, and computed tomography.

According to the World Health Organization (WHO) estimates, in 2022, cancer is the leading cause of death worldwide, resulting in approximately 10 million deaths in 2020, or nearly one in six deaths.

Market Dynamics:

Driver:

Rising demand for early disease detection

Early detection of diseases is crucial, as it enhances the chances of successful treatment and improves patient outcomes. CAD systems integrated with imaging modalities analyze the images and highlight potential areas of concern, aiding radiologists in the early detection of diseases. Moreover, the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has heightened the need for early diagnosis. Therefore, growing demand for early disease detection is a significant driver accelerating market demand.

Restraint:

High implementation costs

High implementation costs pose a significant restraint to the adoption of computer-aided detection (CAD) systems on the market. Implementing CAD systems requires substantial investment, which includes the cost of acquiring the software, hardware infrastructure, and training of healthcare professionals. CAD software itself can be expensive, especially if it is designed for specific medical specialties or imaging modalities. Additionally, the hardware requirements to support CAD systems, such as high-performance computers and storage solutions, can add to the overall implementation costs.

Opportunity:

Evolution of medical imaging technologies

The continuous evolution of medical imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), and mammography, has paved the way for more sophisticated and detailed diagnostic capabilities. These advancements not only enhance the quality of medical imaging but also create opportunities for CAD systems to excel in their ability to detect subtle abnormalities and assist healthcare professionals in making accurate diagnoses. These innovations in medical imaging technologies accelerate market expansion.

Threat:

Data privacy

The implementation of CAD involves the processing and storage of sensitive patient data, including medical images and associated health records. As CAD systems analyze and interpret this information, there is a heightened concern for potential breaches and unauthorized access. Maintaining the privacy and security of patient data is crucial to complying with healthcare regulations and building trust among patients and healthcare providers. Therefore, data privacy is a significant concern, hindering market demand.

COVID-19 Impact

The increased focus on healthcare and diagnostics during the pandemic has underscored the importance of advanced technologies like CAD in detecting and monitoring diseases. The demand for more accurate and efficient diagnostic tools has risen, driving interest in CAD solutions that can aid in the interpretation of medical images, especially in the context of respiratory illnesses such as COVID-19. However, the pandemic has also presented challenges for the CAD market. Financial constraints on healthcare facilities, coupled with disruptions in the supply chain, have affected the adoption of CAD systems.

The nuclear resonance imaging segment is expected to be the largest during the forecast period

The nuclear resonance imaging segment is estimated to hold the largest share. In computer-aided detection, nuclear resonance imaging plays a significant role in enhancing the accuracy and efficiency of image analysis. CAD systems utilize the detailed images generated by nuclear resonance imaging to identify potential abnormalities or suspicious patterns that may indicate the presence of a disease or condition. Moreover, the integration of NRI with CAD technology has led to improved detection rates, reduced false positives, and enhanced overall diagnostic accuracy.

The oncology segment is expected to have the highest CAGR during the forecast period

The oncology segment is anticipated to have lucrative growth during the forecast period. CAD technologies play a transformative role in oncology by aiding healthcare professionals in the early detection and characterization of cancerous lesions through the analysis of medical imaging data. In modalities like mammography, CT scans, and MRI, CAD systems utilize advanced algorithms to identify subtle abnormalities, potential tumours, and irregularities in tissue structures that may be indicative of cancer.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period. The demand for CAD solutions in this region is escalating due to increasing awareness of the benefits of early disease detection and a rising prevalence of diseases like cancer. Governments across Asia-Pacific are investing significantly in healthcare modernization, fostering an environment conducive to CAD market expansion. Additionally, in countries like China and India, where large populations contribute to a high disease burden, CAD systems are gaining traction for their role in improving diagnostic accuracy and efficiency.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, owing to robust healthcare infrastructure, coupled with a high prevalence of chronic diseases, positions CAD as a crucial component in diagnostic workflows. The United States, in particular, dominates the North American CAD market, owing to substantial investments in research and development, a well-established healthcare sector, and a proactive approach to integrating cutting-edge technologies.

Key players in the market:

Some of the key players in the Computer Aided Detection Market include Hologic Inc, CANON Medical Systems Corporation, EDDA Technology, Inc, Koninklijke Philips N.V, Siemens, FUJIFILM Holdings Corporation, NANO-X Imaging LTD., General Electric, IBM, Riverain Technologies, iCAD Inc, Median Technologies, Carestream Health, Shimadzu Analytical (India) Pvt. Ltd and Karyopharm.

Key Developments:

In October 2023, Hologic, Inc., a global leader in women's health, announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical.

In October 2023, Hologic, Inc., a global leader in women's health, announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical. Hologic becomes the chief provider of hystero scopes for AAGL's Essentials in Minimally Invasive Gynecologic Surgery (EMIGS) hands-on hysteroscopy skills training for OB-GYN residents.

Product Types Covered:

  • Abdominal CAD
  • Prostrate CAD
  • Breast CAD
  • Cardiovascular CAD
  • Other Product Types

Indications Covered:

  • Ultrasound Resonance Imaging
  • X-ray Imaging
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Nuclear Resonance Imaging
  • Mammography
  • Other Indications

Applications Covered:

  • Oncology
  • Cardiovascular and Neurological Cancer

End Users Covered:

  • Diagnostic Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Computer Aided Detection Market, By Product Type

  • 5.1 Introduction
  • 5.2 Abdominal CAD
  • 5.3 Prostrate CAD
  • 5.4 Breast CAD
  • 5.5 Cardiovascular CAD
  • 5.6 Other Product Types

6 Global Computer Aided Detection Market, By Indication

  • 6.1 Introduction
  • 6.2 Ultrasound Resonance Imaging
  • 6.3 X-ray Imaging
  • 6.4 Magnetic Resonance Imaging
  • 6.5 Computed Tomography
  • 6.6 Nuclear Resonance Imaging
  • 6.7 Mammography
  • 6.8 Other Indications

7 Global Computer Aided Detection Market, By Application

  • 7.1 Introduction
  • 7.2 Oncology
    • 7.2.1 Colorectal Cancer
    • 7.2.2 Breast Cancer
    • 7.2.3 Prostate Cancer
    • 7.2.4 Lung Cancer
    • 7.2.5 Bone Cancer
    • 7.2.6 Liver Cancer
  • 7.3 Cardiovascular and Neurological Cancer

8 Global Computer Aided Detection Market, By End User

  • 8.1 Introduction
  • 8.2 Diagnostic Centers
  • 8.3 Hospitals
  • 8.4 Other End Users

9 Global Computer Aided Detection Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Hologic, Inc
  • 11.2 CANON Medical Systems Corporation
  • 11.3 EDDA Technology, Inc
  • 11.4 Koninklijke Philips N.V
  • 11.5 Siemens
  • 11.6 FUJIFILM Holdings Corporation
  • 11.7 NANO-X Imaging LTD.
  • 11.8 General Electric
  • 11.9 IBM
  • 11.10 Riverain Technologies
  • 11.11 iCAD Inc
  • 11.12 Median Technologies
  • 11.13 Carestream Health
  • 11.14 Shimadzu Analytical (India) Pvt. Ltd
  • 11.15 Karyopharm

List of Tables

  • Table 1 Global Computer Aided Detection Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Computer Aided Detection Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Computer Aided Detection Market Outlook, By Abdominal CAD (2021-2030) ($MN)
  • Table 4 Global Computer Aided Detection Market Outlook, By Prostrate CAD (2021-2030) ($MN)
  • Table 5 Global Computer Aided Detection Market Outlook, By Breast CAD (2021-2030) ($MN)
  • Table 6 Global Computer Aided Detection Market Outlook, By Cardiovascular CAD (2021-2030) ($MN)
  • Table 7 Global Computer Aided Detection Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 8 Global Computer Aided Detection Market Outlook, By Indication (2021-2030) ($MN)
  • Table 9 Global Computer Aided Detection Market Outlook, By Ultrasound Resonance Imaging (2021-2030) ($MN)
  • Table 10 Global Computer Aided Detection Market Outlook, By X-ray Imaging (2021-2030) ($MN)
  • Table 11 Global Computer Aided Detection Market Outlook, By Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 12 Global Computer Aided Detection Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 13 Global Computer Aided Detection Market Outlook, By Nuclear Resonance Imaging (2021-2030) ($MN)
  • Table 14 Global Computer Aided Detection Market Outlook, By Mammography (2021-2030) ($MN)
  • Table 15 Global Computer Aided Detection Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 16 Global Computer Aided Detection Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Computer Aided Detection Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 18 Global Computer Aided Detection Market Outlook, By Colorectal Cancer (2021-2030) ($MN)
  • Table 19 Global Computer Aided Detection Market Outlook, By Breast Cancer (2021-2030) ($MN)
  • Table 20 Global Computer Aided Detection Market Outlook, By Prostate Cancer (2021-2030) ($MN)
  • Table 21 Global Computer Aided Detection Market Outlook, By Lung Cancer (2021-2030) ($MN)
  • Table 22 Global Computer Aided Detection Market Outlook, By Bone Cancer (2021-2030) ($MN)
  • Table 23 Global Computer Aided Detection Market Outlook, By Liver Cancer (2021-2030) ($MN)
  • Table 24 Global Computer Aided Detection Market Outlook, By Cardiovascular and Neurological Cancer (2021-2030) ($MN)
  • Table 25 Global Computer Aided Detection Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global Computer Aided Detection Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 27 Global Computer Aided Detection Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 28 Global Computer Aided Detection Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.